Matches in Wikidata for { <http://www.wikidata.org/entity/Q91437804> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q91437804 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91437804 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91437804 description "scientific article published on 09 February 2019" @default.
- Q91437804 description "wetenschappelijk artikel" @default.
- Q91437804 description "наукова стаття, опублікована 9 лютого 2019" @default.
- Q91437804 name "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 name "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 type Item @default.
- Q91437804 label "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 label "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 prefLabel "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 prefLabel "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy s" @default.
- Q91437804 P1433 Q91437804-DB382131-C959-4CF6-975E-A0F63D978861 @default.
- Q91437804 P1476 Q91437804-6ECEFE5B-22DE-42E3-A7D9-B422ED8D7712 @default.
- Q91437804 P2093 Q91437804-020AA382-6D75-4393-85AA-DC7D1055A9F4 @default.
- Q91437804 P2093 Q91437804-62A732A3-3197-45A8-B2A7-6D91145813DB @default.
- Q91437804 P2093 Q91437804-7A61F2E8-D752-4146-9978-336611EB9D59 @default.
- Q91437804 P2093 Q91437804-92421C61-517E-4F10-9F6A-589C413BF366 @default.
- Q91437804 P2093 Q91437804-A56EB081-CB16-4758-ACEE-EAEBE0B5038E @default.
- Q91437804 P2093 Q91437804-CD1D4AE1-A9C1-4D3B-A3AA-38F0960FE704 @default.
- Q91437804 P2093 Q91437804-D1FA3644-9FEA-4089-9860-7331BB24011C @default.
- Q91437804 P2093 Q91437804-EB793274-FD9A-40AC-ABD0-82A9F57D096B @default.
- Q91437804 P304 Q91437804-AEED32EA-8C13-4E1C-830B-14EC580B3F81 @default.
- Q91437804 P31 Q91437804-A6AD01BC-8ECB-4F37-8B49-55B2074726A0 @default.
- Q91437804 P356 Q91437804-495AEFBA-89D8-4C03-83AF-0686C277465E @default.
- Q91437804 P433 Q91437804-6E0AE6D9-C628-4A37-B888-11FDC65079AE @default.
- Q91437804 P478 Q91437804-90DBAD4E-EAA6-42AD-8EB9-79075791C402 @default.
- Q91437804 P577 Q91437804-E0868711-EED2-4F1D-99FE-99F5249CE30C @default.
- Q91437804 P698 Q91437804-60C94FC6-CB5A-459E-A801-19DE6AF92329 @default.
- Q91437804 P921 Q91437804-0237939E-EEB1-4767-8FB1-900FEF0904F9 @default.
- Q91437804 P921 Q91437804-B48E567F-9B97-4D43-AC23-ED0C3D25AC94 @default.
- Q91437804 P921 Q91437804-C74E3D3B-D922-4920-A123-8730986F3C7D @default.
- Q91437804 P356 S00011-019-01218-Y @default.
- Q91437804 P698 30739130 @default.
- Q91437804 P1433 Q1819367 @default.
- Q91437804 P1476 "Toreforant, an orally active histamine H4-receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate: mechanism of action results from a phase 2, multicenter, randomized, double-blind, placebo-controlled synovial biopsy study" @default.
- Q91437804 P2093 "Cesar Calderon" @default.
- Q91437804 P2093 "David L Boyle" @default.
- Q91437804 P2093 "Dion Chen" @default.
- Q91437804 P2093 "Gary S Firestein" @default.
- Q91437804 P2093 "Paul J Dunford" @default.
- Q91437804 P2093 "Robin L Thurmond" @default.
- Q91437804 P2093 "Samuel E DePrimo" @default.
- Q91437804 P2093 "William Barchuk" @default.
- Q91437804 P304 "261-274" @default.
- Q91437804 P31 Q13442814 @default.
- Q91437804 P356 "10.1007/S00011-019-01218-Y" @default.
- Q91437804 P433 "4" @default.
- Q91437804 P478 "68" @default.
- Q91437804 P577 "2019-02-09T00:00:00Z" @default.
- Q91437804 P698 "30739130" @default.
- Q91437804 P921 Q187255 @default.
- Q91437804 P921 Q269829 @default.
- Q91437804 P921 Q422232 @default.